ScholarIQanswers from OpenAlex & ORCID
William D. Figg
ResearcherPublications, citations & collaboration network
William D. Figg is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does William D. Figg have?
ScholarIQindexed works
William D. Figg has 1,213 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does William D. Figg have?
ScholarIQcitation count
William D. Figg has 38,477 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of William D. Figg?
ScholarIQh-index
William D. Figg has an h-index of 102 in OpenAlex.
What is the i10-index of William D. Figg?
ScholarIQi10-index
William D. Figg has an i10-index of 477 in OpenAlex.
What is the ORCID of William D. Figg?
ScholarIQorcid
The ORCID for William D. Figg is on the source record.
What is the OpenAlex record for William D. Figg?
ScholarIQopenalex
The OpenAlex for William D. Figg is on the source record.
What are the most-cited papers on William D. Figg?
ScholarIQmost cited works
Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group
Glenn J. Bubley, Michael A. Carducci, William L. Dahut, Nancy A. Dawson, Danai Daliani, Mario A. Eisenberger, William D. Figg, Boris Freidlin, Susan Halabi, Gary R. Hudes, Maha Hussain, Richard Kaplan, Charles E. Myers, William Oh, Daniel P. Petrylak, Eddie Reed, Bruce J. Roth, Oliver Sartor, Howard I. Scher, Jonathan W. Simons, Vickie Sinibaldi, Eric J. Small, Matthew R. Smith, Donald L. Trump, Robin T. Vollmer, George Wilding
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tatyana Worthy, William D. Figg, Cody J. Peer, Michael C. Sneller, H. Clifford Lane, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Andrea M. Gross, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher, Brian Weiss, AeRang Kim, Miriam Bornhorst, Amish C. Shah, Staci Martin, Marie Claire Roderick, Dominique C. Pichard, Amanda Carbonell, Scott M. Paul, Janet Therrien, Oxana B. Kapustina, Kara Heisey, D. Wade Clapp, Chi Zhang, Cody J. Peer, William D. Figg, Malcolm A. Smith, John Glod, Jaishri O. Blakeley, Seth M. Steinberg, David Venzon, L. Austin Doyle, Brigitte C. Widemann
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy
Alex Sparreboom, Romano Danesi, Yukio Ando, Juliana C.N. Chan, William D. Figg
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli, Kelli M. Wilson, Yang Zhang, Erin Beck, Linda Sciuto, Samantha Nichols, Brian Elenbaas, Janusz Puc, Heike Dahmen, Astrid Zimmermann, Jillian Varonin, Christopher W. Schultz, Se Hyun Kim, Hirity Shimellis, Parth Desai, Carleen Klumpp‐Thomas, Lu Chen, Jameson Travers, Crystal McKnight, Sam Michael, Zina Itkin, Sunmin Lee, Akira Yuno, Min-Jung Lee, Christophe E. Redon, Jessica D. Kindrick, Cody J. Peer, Jun S. Wei, Mirit I. Aladjem, William D. Figg, Seth M. Steinberg, Jane B. Trepel, Frank T. Zenke, Yves Pommier, Javed Khan, Craig J. Thomas